Elsevier

Cardiology Clinics

Volume 25, Issue 3, August 2007, Pages 457-466
Cardiology Clinics

How to Manage Athletes with Syncope

https://doi.org/10.1016/j.ccl.2007.07.005Get rights and content

Athletes with syncope warrant a full evaluation, as it is possible that athletics may unmask heart disease, either structural or electrical, and these athletes may be at risk for sudden cardiac death. The work-up and treatment of syncope in the athlete offers some unique challenges: to diagnose potentially life-threatening arrhythmias, to avoid pharmacological therapy, and to maximize ability to play. This article addresses the topic of syncope and possible solutions for those athletes in whom it is diagnosed.

Section snippets

Incidence

In the general population, syncope is seen in up to 40% over a lifetime. The authors have had little information on the incidence in the athlete until recently, when data from the Italian screening programs have become available. In this recent series, Colivicchi and colleagues reported on 7568 athletes screened for athletic participation [7]. In these, 474 (6.2%) reported a syncopal spell in the preceding 5 years. Syncope was unrelated to exercise in 87.7%, postexertional in 12.0%, and

Risks of exercise

Although the long-term benefit of exercise has been shown to decrease the mortality of a number of diseases, this beneficial effect does not come without some acute risk. A number of investigators have shown that there is an increased risk of sudden death in athletes with underlying cardiovascular disease, including the young [8], [9], [10], [11]. During exercise, mechanisms for the increased risk of sudden death include plaque rupture, caused by shear stress, and subsequent coronary

Workup of the athlete with syncope

The athlete with syncope presents a unique challenge to the physician. Syncope in young individuals is usually benign; however, syncope can be a warning of impending SCD, especially in those with diagnosed or undiagnosed heart disease [14], [15], [16], [17]. The etiology of syncope in these young healthy individuals ranges from benign neurocardiogenic syncope to nonsustained life-threatening arrhythmias. In these individuals, in whom most will have benign causes of syncope, it is critically

Neurally mediated syncope

Neurocardiogenic syncope is the most common cause of syncope in the young individual. This disorder is characterized by occurring during upright posture, frequent situational triggers, and premonitory symptoms of warmth, lightheadedness, palpitations, sweating, and pallor. Loss of consciousness occurs over 5 to 10 seconds, often causing ā€œslumping,ā€ although some episodes may be quite abrupt. Patients typically regain consciousness rapidly, but feelings of fatigue continue. More recently, it has

Summary

Athletes with syncope warrant a full evaluation. These athletes may suffer from neurocardiogenic syncope, the most common cause of syncope in the young. In this case their prognosis is excellent and they can continue to compete. However, it is also possible that athletics may unmask heart disease, either structural or electrical, and these athletes may be at risk of sudden cardiac death. The workup and treatment of syncope in the athlete offers some unique challenges: to diagnose potentially

References (76)

  • D. Kosinski et al.

    Exercise-induced neurocardiogenic syncope

    Am Heart J

    (1996)
  • R. Serra-Grima et al.

    Marked ventricular repolarization abnormalities in highly trained athletes' electrocardiograms: clinical and prognostic implications

    J Am Coll Cardiol

    (2000)
  • M. Zehender et al.

    ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance

    Am Heart J

    (1990)
  • G.J. Balady et al.

    Electrocardiogram of the athlete: an analysis of 289 professional football players

    Am J Cardiol

    (1984)
  • C.M. Oakley

    The electrocardiogram in the highly trained athlete

    Cardiol Clin

    (1992)
  • K. Wang et al.

    Electrocardiograms of Wolff-Parkinson-White syndrome simulating other conditions

    Am Heart J

    (1996)
  • P. Ott et al.

    Electrocardiographic markers of sudden death

    Cardiol Clin

    (2006)
  • W. Zareba

    Genotype-specific ECG patterns in long QT syndrome

    J Electrocardiol

    (2006)
  • D.G. Benditt et al.

    ACC Expert Consensus Document: Tilt table testing for assessing syncope

    J Am Coll Cardiol

    (1996)
  • B.J. Maron et al.

    Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes With Cardiovascular Abnormalities

    J Am Coll Cardiol

    (2005)
  • D. Corrado et al.

    Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study

    J Am Coll Cardiol

    (1997)
  • A.J. Sauer et al.

    Long QT syndrome in adults

    J Am Coll Cardiol

    (2007)
  • M.S. Link et al.

    Syncope in athletes

    Cardiovasc Rev Rep

    (2002)
  • N.A. Estes et al.

    Report of the NASPE policy conference on arrhythmias and the athlete

    J Cardiovasc Electrophysiol

    (2001)
  • B.J. Maron et al.

    Sudden death in young athletes

    Circulation

    (1980)
  • B.D. Murdoch

    Loss of consciousness in healthy South African men: incidence, causes and relationship to EEG abnormality

    S Afr Med J

    (1980)
  • F. Colivicchi et al.

    Epidemiology and prognostic implications of syncope in young competing athletes

    Eur Heart J

    (2004)
  • C.M. Albert et al.

    Triggering of sudden death from cardiac causes by vigorous exertion

    N Engl J Med

    (2000)
  • M.A. Mittleman et al.

    Triggering of acute myocardial infarction by heavy physical exertion

    N Engl J Med

    (1993)
  • D. Corrado et al.

    Exercise and the risk of sudden cardiac death

    Herz

    (2006)
  • G.H. Tofler

    Triggers of sudden cardiac death in the athlete

  • P.D. Thompson

    The Cardiovascular risks of exercise

  • S.A. Strickberger et al.

    AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society

    Circulation

    (2006)
  • B.J. Maron

    Sudden death in young athletes

    N Engl JĀ Med

    (2003)
  • B.J. Maron et al.

    The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death

    Circulation

    (2006)
  • A. Pelliccia et al.

    Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes

    Eur Heart J

    (2006)
  • B.J. Maron et al.

    Clinical profile and spectrum of commotio cordis

    JAMA

    (2002)
  • W.N. Kapoor

    Evaluation and outcome of patients with syncope

    Medicine (Baltimore)

    (1990)
  • Cited by (0)

    View full text